NYSE : ABT

Abbott Laboratories

$103.1 USD

$2.35 (2.33%)

Volume
8.64M
Average Volume
13.4M
Market Capitalization
$179.58B
P/E Ratio
33.15
Dividend Yield
2.41%
Price Target
$120.00
Year High
$137.49
Year Low
$81.97
Day High
—
Day Low
—
Payout Ratio
$0.77
Current Ratio
$1.39
Company Overview

NYSE

Robert Ford

Medical - Devices

Healthcare

ABT

114000

US

USD

https://www.abbott.com

224 667 6100

002824100

0000001800

Liquidity Metrics

0.65

1.39

1.01

0.37

0.77

Sales & Valuation

$44.33B

3.85

3.45

24.34

4.23

Profitability

$3.72

$6.52B

11.65%

16.12%

10.55%

4.91%

P/E Metrics

33.15

-0.54

-0.54

Analyst Price Target & Rating

$120.00

$145.00

$92.00

Sell

2/5

41 Analysts

-14.08%

Financial Health Scores

3.24

5/9

$7.13B

$110.43B

$57.73B

$8B

Key Metrics (TTM)

$206.82B

4.44

20.80

1.39

10.55%

5.94%

3.02%

4.11%

$45.73

106 days

Company Executives
Name Title
Daniel Gesua Sive Salvadori Executive Vice President and Group President of Established Pharmaceuticals & Nutritional Products
Elizabeth Cushman Executive Vice President, General Counsel & Secretary
Christopher J. Scoggins Executive Vice President of Diabetes Care
Scott Michael Leinenweber Senior Vice President of Licensing, Acquisitions & Ventures
Mary K. Moreland Executive Vice President of Human Resources
Robert Ford Executive Chairman, President & CEO
Michael Comilla Vice President of Investor Relations.
Sabina Ewing Senior Vice President of Business & Technology Services and Chief Information Officer
Erica L. Battaglia Vice President and Chief Ethics & Compliance Officer
Melissa Brotz Senior Vice President of Global Marketing & External Affairs
Philip Boudreau Chief Financial Officer & Executive Vice President of Finance
Lisa D. Earnhardt Executive Vice President & Group President of Medical Devices
Poll Results

No votes yet today — be the first to share your view!

About Abbott Laboratories (NYSE:ABT) Stock

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, infla ... mmation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.

Bank of Nova Scotia Trims Stock Holdings in Abbott Laboratories $ABT

2026-07-26 03:57:35

Bank of Nova Scotia lessened its holdings in shares of Abbott Laboratories (NYSE: ABT) by 16.8% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 259,747 shares of the healthcare product maker's stock after selling 52,490 shares during the

Q2 Earnings: Guidance Upgrades Push These 3 Stocks Higher

2026-07-24 12:16:07

Companies raising guidance, particularly on the earnings front, always deserve some level of attention from investors. Recently, JNJ, GM, and ABT have all raised their outlooks.

ISRG vs. ABT: Which MedTech Giant Is the Smarter Investment Now?

2026-07-23 15:11:05

ISRG's expanding robotic surgery ecosystem and innovation pipeline give it an edge over Abbott for investors seeking stronger long-term MedTech growth.

23,500 Shares in Abbott Laboratories $ABT Purchased by B&D White Capital Company LLC

2026-07-23 05:15:00

B&D White Capital Company LLC bought a new stake in shares of Abbott Laboratories (NYSE: ABT) during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 23,500 shares of the healthcare product maker's stock, valued at approximately $2,413,000. Other

Abbott Laboratories $ABT Shares Acquired by ABN Amro Investment Solutions

2026-07-23 03:49:42

ABN Amro Investment Solutions increased its stake in Abbott Laboratories (NYSE: ABT) by 10.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 92,222 shares of the healthcare product maker's stock after purchasing an additional 9,071 shares during the quarter. ABN

3 Reasons to Buy AbbVie Stock Like There's No Tomorrow

2026-07-21 18:30:00

It looks like a great buy-and-hold option.

Johnson & Johnson vs Abbott Laboratories: Two Healthcare Giants on Opposite Trajectories

2026-07-21 11:00:39

Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) and Abbott Laboratories (NYSE:ABT) both recently posted earnings that show two healthcare giants moving in opposite strategic directions.

Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know

2026-07-21 10:02:22

Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Frequently Asked Questions

What is the current Abbott Laboratories (ABT) stock price?

Abbott Laboratories(NYSE:ABT) stock price is $103.1 in the last trading session. During the trading session, ABT stock reached the peak price of $137.49 while $81.97 was the lowest point it dropped to. The percentage change in ABT stock occurred in the recent session was 2.33% while the dollar amount for the price change in ABT stock was $2.35.

ABT's industry and sector of operation?

The NYSE listed ABT is part of Medical - Devices industry that operates in the broader Healthcare sector.

Who are the executives of ABT?

Daniel Gesua Sive Salvadori | Executive Vice President and Group President of Established Pharmaceuticals & Nutritional Products
Elizabeth Cushman | Executive Vice President, General Counsel & Secretary
Christopher J. Scoggins | Executive Vice President of Diabetes Care
Scott Michael Leinenweber | Senior Vice President of Licensing, Acquisitions & Ventures
Mary K. Moreland | Executive Vice President of Human Resources

How many employees does ABT have?

Number of ABT employees currently stands at 114000. ABT operates from 100 Abbott Park Road, Abbott Park, IL 60064-6400, US.

Link for ABT official website?

Official Website of ABT is: https://www.abbott.com

How do I contact ABT?

ABT could be contacted at phone #224 667 6100 and can also be accessed through its website. ABT operates from 100 Abbott Park Road, Abbott Park, IL 60064-6400, US.

How many shares of ABT are traded daily?

The average number of ABT shares traded daily for last 3 months was 13.4M.

What is the market cap of ABT currently?

The market value of ABT currently stands at $179.58B with its latest stock price at $103.1